SonoVue

SonoVue Use In Pregnancy & Lactation

Manufacturer:

Bracco

Distributor:

DCH Auriga
Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: No clinical data on exposed pregnancies are available. Animal studies do not indicate harmful effects with respect to pregnancy, embryonal/foetal development, parturition or postnatal development (see Pharmacology: Toxicology: Preclinical safety data under Actions). As a precautionary measure, it is preferable to avoid the use of SonoVue during pregnancy.
Breastfeeding: It is not known if sulphur hexafluoride is excreted in human milk. However, based on its rapid elimination from the body via the expired air, it is considered that the breastfeeding can be resumed two to three hours after administration of SonoVue.
Fertility: No clinical data are available. Animal studies do not indicate harmful effects on fertility.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in